TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health & Fitness

    JAMA Clinical Reviews

    Author interviews that explore the latest clinical reviews.

    Advertise

    Copyright: © 2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Phenome-Wide Association Studies Nov 15, 2022
    Show notes

    Phenome-wide association studies use large data sets to search for phenotypes associated with specific single-nucleotide variants, investigating whether specific genetic variations may be associated with multiple conditions and traits. In this podcast, JAMA Fishbein Fellow Revital Marcus, MD, discusses phenome-wide association studies with Dan M. Roden, MD, professor of medicine, pharmacology, and biomedical informatics at Vanderbilt University Medical Center, and Joshua C. Denny, MD, MS, chief executive officer of the National Institutes of Health's All of Us Research Program. Related Content:

    • Phenome-Wide Association Studies

    Treatment of Hypertension in 2022 Nov 08, 2022
    Show notes

    JAMA Interim Executive Editor Gregory Curfman, MD, interviews Robert M. Carey, MD, University of Virginia, about his review article on treatment of hypertension in the November 8, 2022, issue of JAMA. Their discussion addresses the clinical consequences of hypertension, as well as nonpharmacological and pharmacological approaches to management, including patients with resistant hypertension. Related Content:

    • Treatment of Hypertension

    Medication Abortion Using Mifepristone and Misoprostol Nov 01, 2022
    Show notes

    JAMA Associate Editor Linda Brubaker, MD, MS, discusses medication abortion as an alternative to a procedural abortion to terminate a pregnancy in an interview with Stephanie Teal, MD, MPH, University Hospitals Cleveland Medical Center, and Rebecca Cohen, MD, OB/GYN, University of Colorado.

    Related Content:

    • Medication Abortion
    • Contraception Selection, Effectiveness, and Adverse Effects

    Conflict of Interest Disclosures: Dr Cohen serves as an unpaid board member for Cobalt, a reproductive rights advocacy group. No other disclosures were reported.


    The Future of Ob-Gyn Training in the US Post-Dobbs Nov 01, 2022
    Show notes

    An estimated 45% of accredited US obstetrics and gynecology residency programs are located in states that currently ban or severely restrict abortions. JAMA Associate Editor Linda Brubaker, MD, and JAMA Internal Medicine Deputy Editor Deborah Grady, MD, speak with medical students, program directors, and other specialists in the ob-gyn training community about new restrictions and their effects on ob-gyn education in the US. Related Content:

    • Implications of the Dobbs Decision for Medical Education
    • Dobbs Decision Threatens Full Breadth of Ob-Gyn Training
    • Medical Indications for Abortion
    • Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions
    • Treating Cancer in Pregnant Patients After Roe v Wade Overturned
    • The Challenge of Emergency Abortion Care Following the Dobbs Ruling
    • Clinical and Legal Dilemmas of Providing Reproductive Health Care After the Dobbs Decision
    • Legal Risks and Ethical Dilemmas for Clinicians in the Aftermath of Dobbs
    • The Implications of the Supreme Court Decision to Overturn Roe v Wade for Women With Pregnancy-Associated Cancers
    • Reproductive Rights in Neurology—The Supreme Court's Impact on All of Us
    • Antiabortion Laws and Implications for Patients With Cardiovascular Disease in Pregnancy

    Conflict of Interest Disclosures:

    Hannah Nguyen reported that she held leadership positions on Boston University's School of Medicine chapters of SPA-1 and DREAM. Margaux Zimmerman reported that she held leadership positions on Boston University's, School of Medicine chapters of ACOG and DREAM. Dr Gariepy reported that she was the Yale Complex Family Planning fellowship director from 2018 to March 2022, for which she received salary support from her institution; taught undergraduate and medical students, ob-gyn residents, and Complex Family Planning fellows; and is a research mentor for Complex Family Planning fellows who received research grants from the Society of Family Planning Research Fund. Dr Gariepy also reported leadership positions on the board of directors for the Society of Family Planning and the Complex Family Planning Fellowship Council and membership with Physicians for Reproductive Health, the National Abortion Federation, and the Society of Family Planning. Dr Steinauer is a member of the Society of Family Planning. Dr Loder reported that she serves as a principal investigator for contraceptive clinical trials for Merck and Sebela Pharmaceuticals Inc, consults for American Medical Students Association, and serves as program director for Complex Family Planning Fellowship, University of Michigan, Michigan Medicine. No other disclosures were reported.


    Clinical and Legal Dilemmas of Providing Reproductive Health Care After the Dobbs Decision Nov 01, 2022
    Show notes

    Michele Bratcher Goodwin, JD (Center for Biotechnology and Global Health Policy, University of California, Irvine), Molly Meegan, JD (American College of Obstetricians and Gynecologists), and Lisa Harris, MD, PhD (University of Michigan) discuss how new abortion bans in the US are creating serious legal and ethical dilemmas for clinicians. Hosted by JAMA Legal and Global Health Correspondent Lawrence O. Gostin, JD (Georgetown University). Related Content:

    • Legal Risks and Ethical Dilemmas for Clinicians in the Aftermath of Dobbs
    • The Future of Ob-Gyn Training in the US Post-Dobbs
    • Medical Indications for Abortion

    Conflict of Interest Disclosures:

    Lawrence O. Gostin, JD, is the Legal and Global Health Correspondent for JAMA and Faculty Director of the O'Neill Institute for National and Global Health Law at Georgetown University. No other disclosures were reported.

    Michele Bratcher Goodwin, JD, LLM, SJD is Director of the Center for Biotechnology and Global Health Policy at University of California, Irvine. No other disclosures were reported. Lisa Harris, MD, PhD, is the F. Wallace and Janet Jeffries Collegiate Professor of Reproductive Health, and Professor and Associate Chair in the Department of Obstetrics and Gynecology at University of Michigan. She is also a Professor in the Department of Women's Studies. No other disclosures reported. Molly Meegan is the Chief Legal Officer and General Counsel for the American College of Obstetricians and Gynecologists (ACOG). No other disclosures reported.


    Hypercalcemia—A Review Oct 25, 2022
    Show notes

    Hypercalcemia affects approximately 1% of the population. Its presence typically indicates an underlying disorder and requires diagnostic evaluation. In this podcast, JAMA Associate Editor Anne Cappola, MD, ScM, interviews Elizabeth Shane, MD, an endocrinologist and professor of medicine at Columbia University Medical Center, about the clinical approach to diagnosing and managing hypercalcemia. Related Content:

    • Hypercalcemia

    Diagnosis and Management of Acute Pulmonary Embolism Oct 04, 2022
    Show notes

    In the US, pulmonary embolism (PE) affects approximately 370 000 patients annually and is estimated to cause 60 000 to 100 000 deaths per year. In this podcast, JAMA Senior Editor Kristin Walter, MD, MS, discusses the clinical presentation, diagnostic strategies, and treatment of PE with Yonathan Freund, MD, PhD, professor of emergency medicine at Sorbonne University in Paris, France.

    Related Article(s):

    • Acute Pulmonary Embolism

    Diagnosis and Management of Hyponatremia Sep 30, 2022
    Show notes

    Hyponatremia affects approximately 5% of adults and approximately 35% of hospitalized patients. Even mild hyponatremia can be associated with cognitive impairment; in hospitalized patients, hyponatremia is associated with longer hospital stays and increased mortality. In this podcast, JAMA Deputy Editor Mary M. McDermott, MD, interviews Nicolaos E. Madias, MD, a nephrologist and professor of medicine at Tufts University School of Medicine, about the clinical approach to diagnosing hyponatremia and management of both acute and chronic hyponatremia.

    Related Content:

    Diagnosis and Management of Hyponatremia


    Diagnosis and Management of Myelodysplastic Syndromes Sep 06, 2022
    Show notes

    Myelodysplastic neoplasms, or myelodysplastic syndromes, are diagnosed in approximately 4 of 100 000 people each year in the US and are associated with a 5-year survival rate of approximately 37%. In this JAMA podcast and author interview, JAMA Deputy Editor Mary M. McDermott, MD, discusses the diagnosis and treatment of myelodysplastic syndromes with Mikkael A. Sekeres, MD, MS, chief of hematology and professor of medicine of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

    Related Content:

    Diagnosis and Treatment of Myelodysplastic Syndromes


    Update on Monkeypox Aug 26, 2022
    Show notes

    JAMA Associate Editor Preeti Malani, MD, MSJ, discusses testing, treatment, and prevention of monkeypox infection and the current state of the 2022 outbreak with Carlos del Rio, MD, from Emory University's Department of Medicine. Recorded August 19, 2022. Related Content:

    • Monkeypox in 2022—What Clinicians Need to Know
    • What Is Monkeypox?
    • What to Know About Monkeypox
    • Global Monkeypox Outbreaks Spur Drug Research for the Neglected Disease
    • Diagnosis, Prevention, and Treatment of Monkeypox
    • Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection

    Previous 1 19 20 21 22 23 51 Next

    Related Podcasts

    Fresh Air

    1

    Fresh Air Arts
    Twenty Thousand Hertz

    2

    Twenty Thousand Hertz Arts
    The Black Tapes

    3

    The Black Tapes Arts
    Snap Judgment

    4

    Snap Judgment Arts
    Here’s The Thing with Alec Baldwin

    5

    Here’s The Thing with Alec Baldwin Arts
    The NoSleep Podcast – Creative Reason Media Inc.

    6

    The NoSleep Podcast – Creative Reason Media Inc. Arts
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights